Patient Navigation Program for Pregnancy
(PATH Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the Patient Navigation Program treatment for pregnancy?
Patient navigation programs have been shown to improve health outcomes by reducing barriers and facilitating timely access to care, as seen in cancer treatment and survivorship. These programs can also enhance satisfaction with healthcare by providing support to underserved populations, suggesting potential benefits for pregnancy care.12345
Is the Patient Navigation Program safe for use in humans?
The Patient Navigation Program has been used in various healthcare settings, including cancer care and perinatal care, to help patients navigate complex healthcare systems. While the research does not specifically address safety concerns, the program is generally considered a supportive intervention aimed at improving healthcare access and outcomes, suggesting it is safe for human use.26789
How does the Patient Navigation Program treatment for pregnancy differ from other treatments?
What is the purpose of this trial?
The Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) study aims to evaluate whether an antenatal patient navigation program improves maternal health, neonatal health, pregnant persons' experiences, and health care utilization outcomes among low-income pregnant individuals and their neonates. Patient navigation is an individualized, barrier-focused, longitudinal, patient-centered intervention that offers support for a defined set of health services. In this randomized controlled trial, pregnant individuals who are randomized to receive antenatal patient navigation will be compared to pregnant individuals who are randomized to receive usual care. Navigators will support birthing people from before 20 weeks of gestation through 2 weeks postpartum. The PATH intervention will be grounded in understanding and addressing social determinants of health in order to promote self-efficacy, enhance access, and sustain long-term engagement.The main objectives of the study are to:1. Evaluate whether PATH, compared to usual care, improves maternal health outcomes. We hypothesize the PATH model of bundled social- and health systems-focused antenatal patient navigation for racially and ethnically diverse low-income individuals will reduce the incidence of a composite of adverse maternal outcomes all known to be associated with socioeconomic disadvantage and SDoH. We will also investigate maternal health care utilization.2. Evaluate whether PATH, compared to usual care, improves perinatal health outcomes. We hypothesize PATH will reduce the incidence of a composite of adverse perinatal outcomes. We will also investigate neonatal/pediatric health care utilization.3. Evaluate patient, clinician, navigator, and healthcare system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim will be accomplished through investigating patient-reported outcomes, completing qualitative and process mapping interviews with navigated participants, and completing qualitative and process mapping interviews with clinicians, navigators, and health administrators.
Research Team
Lynn M Yee, MD, MPH
Principal Investigator
Northwestern University
Eligibility Criteria
The PATH study is for low-income pregnant individuals before 20 weeks of gestation, focusing on those who may benefit from extra support due to socioeconomic disadvantages. It's not specified who can't join, but typically people with certain health conditions or risks might be excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Antenatal Navigation
Participants receive intensive, individualized patient navigation services throughout pregnancy, focusing on social determinants of health and healthcare access.
Postpartum Follow-up
Participants are monitored for maternal and neonatal health outcomes and healthcare utilization up to 9 months postpartum.
Long-term Follow-up
Participants' experiences and outcomes are evaluated through interviews and process mapping to prepare for widespread implementation of the PATH model.
Treatment Details
Interventions
- Patient Navigation Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator